Tag: Health and Medical

AUSTIN, Texas and LONDON, England, Feb. 24, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King's College London.

AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 23, 2021 (SEND2PRESS NEWSWIRE) -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.

ROCKVILLE, Md., Feb. 22, 2021 (SEND2PRESS NEWSWIRE) -- The 19th National Postdoctoral Association (NPA) Annual Conference is set for April 15-16, 2021 and will include educational, career advancement and networking opportunities benefiting postdoctoral scholars ("postdocs") and their host institutions around the world. More than fifty experts will dive into themes of top importance to the greater postdoc community.

HOUSTON, Texas, Feb. 19, 2021 (SEND2PRESS NEWSWIRE) -- C. Bob Basu, MD, MBA, MPH, FACS of Houston is honored to announce the first year of the annual Basu Plastic Surgery Advancing Care Scholarship for Adult Learners. Designed to support adults over the age of 40 who live in Texas as they pursue a graduate degree as a licensed medical practitioner, physician, or nurse.

PORTLAND, Maine, Feb. 18, 2021 (SEND2PRESS NEWSWIRE) -- Zootility, a design-driven US manufacturing company, launches a mask to provide comfort and protection to both those who are wearing masks just for a quick trip to the grocery store as well as essential workers who are masked 8+ hours per day.

HOLLYWOOD, Fla., Feb. 16, 2021 (SEND2PRESS NEWSWIRE) -- Great Speech, Inc., a pioneer in the online speech therapy space, has contracted with Harbour Benefits Holding Inc, to increase access for much-needed virtual speech therapy services to Harbour's plan participants.

SACRAMENTO, Calif., Feb. 12, 2021 (SEND2PRESS NEWSWIRE) -- The field of plastic surgery has long had a gender imbalance: while 92% of patients are women, most plastic surgeons are men. In fact, only 1 out of 5 plastic surgeons is female. This is gradually changing, due in part to women like board certified plastic surgeon Christa Clark, MD, FACS, who employs an all-female staff at her practice, Granite Bay Cosmetic Surgery.

CARY, N.C., Feb. 12, 2021 (SEND2PRESS NEWSWIRE) -- Rescindo Therapeutics Inc., a drug discovery company dedicated to the development of new treatments for rare genetic disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Rare Pediatric Disease Designation for the Company's lead drug RSC-57, for the treatment of patients with Kabuki Syndrome.

IXONIA, Wis., Feb. 9, 2021 (SEND2PRESS NEWSWIRE) -- JNL Technologies, maker of Quantum nurse call, wander management, and access control systems, is now shipping Quantum SA, a standalone wander management system. Using the same proven Bluetooth technology as JNL's Quantum DCS product line, the Quantum SA does not require cable installation or the purchase of a Quantum server and is perfect for smaller areas that do not require centralized management.

BERKELEY, Calif., Feb. 9, 2021 (SEND2PRESS NEWSWIRE) -- Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator's second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD).

NEW YORK, N.Y., Feb. 9, 2021 (SEND2PRESS NEWSWIRE) -- Minority business enterprise (MBE) New York-based development and diversity supplier firm, MRV Group, LLC partners with architectural firm DXA studio to re-invest American made PPE sales to 501(c)(6) and 501(c)(3) organizations that support MWBE's and underserved communities impacted by COVID-19.

AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce the launch of its "Stem the Tide of Time" social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). (VIDEO)

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.

SAN FRANCISCO, Calif., Feb. 4, 2021 (SEND2PRESS NEWSWIRE) -- EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation's largest independent pharmacy benefit consulting firm into EPIC's Employee Benefits Consulting practice.

AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 4, 2021 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) and subsidiary company Pure Transplant Solutions, LLC (PTS), announced today that Blake Harlan has been promoted to President and Rico Buchli, PhD to Vice President of Products and Services.

CORAL SPRINGS, Fla., Feb. 3, 2021 (SEND2PRESS NEWSWIRE) -- HG Doctors recently added a third location to its family of healthcare practices - Coral Springs Medical & Dental. Its one-stop approach to healthcare services is a driving force behind its expansion. This new facility offers primary care/family medicine, geriatrics, senior activities, behavioral health, podiatry and dental care - all under one roof.

MCKINNEY, Texas, Feb. 2, 2021 (SEND2PRESS NEWSWIRE) -- Blockit Inc., a leading provider of digital care coordination solutions, has been on the front lines of the pandemic, providing a no-cost adaptation of their deeply integrated and highly sophisticated healthcare scheduling platform to be utilized toward COVID-19 relief efforts. Today, Blockit announced that its vaccine scheduling solution is now being used by over 350 organizations responsible for scheduling over 400,000 vaccines.

ROCKVILLE, Md., Feb. 1, 2021 (SEND2PRESS NEWSWIRE) -- As advocates for a rewarding postdoctoral experience, the National Postdoctoral Association (NPA) applauds the National Institutes of Health (NIH) for increasing the Ruth L. Kirschstein National Research Service Award (NRSA) stipends for fiscal year 2021.